Literature DB >> 1473297

Assessing vascular reactivity of arteries in the small vessel myograph.

G A McPherson1.   

Abstract

1. Using a small vessel myograph, experiments were performed on rat small mesenteric arteries (and in some cases dog small coronary arteries) to assess the dependence of vasoconstrictor potency (EC50) and maximum response (Emax) on the initial passive conditions and on the mode of recording (i.e. isometric, isobaric or isotonic). 2. Maximum active isometric tension development to methoxamine occurred at different points on the passive diameter--tension curve depending on the origin of the vessel. The point of maximum sensitivity of methoxamine did not coincide with the point of maximum tension development on the passive diameter-tension curve. 3. Vascular reactivity to methoxamine was assessed under isobaric, isotonic and isometric conditions using a new computerized myograph. Methoxamine was significantly more potent, but only by a factor of twofold, when assessed under isometric conditions. In addition, the maximum response to methoxamine, in terms of diameter change, was always greater under isobaric than under isotonic conditions. 4. The results show that, in studies comparing vascular reactivity of vasoactive drugs, the results depend, to some extent, on the initial passive conditions selected. In terms of assessing the pharmacological activity of drugs on isolated blood vessels, the use of common isometric recording procedures are adequate. However, the use of isobaric, isotonic and isometric recording procedures have shown the complexities of vascular reactivity which depend on the passive and active properties of the blood vessel. These factors may need to be taken into account when comparing the reactivity of isolated blood vessels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473297     DOI: 10.1111/j.1440-1681.1992.tb00420.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  18 in total

1.  Functional and electrophysiological effects of a novel imidazoline-based K(ATP) channel blocker, IMID-4F.

Authors:  G A McPherson; K L Bell; J L Favaloro; M Kubo; N B Standen
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries.

Authors:  E Streeter; J Hart; E Badoer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-17       Impact factor: 3.000

3.  Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries.

Authors:  F Jiang; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.

Authors:  F Jiang; G J Dusting
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes.

Authors:  C H Leo; J L Hart; O L Woodman
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Endothelium-dependent noradrenaline-induced relaxation of rat isolated cerebral arteries: pharmacological characterization of receptor subtypes involved.

Authors:  R G Hempelmann; A Ziegler
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Calcium dynamics and vasomotion in arteries subject to isometric, isobaric, and isotonic conditions.

Authors:  Michèle Koenigsberger; Roger Sauser; Dominique Seppey; Jean-Louis Bény; Jean-Jacques Meister
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

8.  Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries.

Authors:  Li-Mei Zhao; Yan Wang; Xiao-Zhen Ma; Nan-Ping Wang; Xiu-Ling Deng
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

9.  Novel imidazoline compounds that inhibit Kir-mediated vasorelaxation in rat middle cerebral artery.

Authors:  Joanne L Favaloro; Karen L Andrews; Grant A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-27       Impact factor: 3.000

10.  Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations.

Authors:  N H Buus; E VanBavel; M J Mulvany
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.